Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 52, 2022 - Issue 19-20
250
Views
5
CrossRef citations to date
0
Altmetric
Articles

Hantzsch-like three-component synthesis of bis(1,4-dihydropyridines) and bis(fused-1,4-dihydropyridines) linked to piperazine core via 2-phenoxyethanone linkage: Novel hybrid molecules

, , , ORCID Icon & ORCID Icon
Pages 1981-1997 | Received 06 Jun 2022, Published online: 20 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hadeel F. Hammad, Ahmed F. Darweesh, Mahfouz A. Abdelaziz, Ahmed H. M. Elwahy & Ismail A. Abdelhamid. (2023) Synthesis of dihydropyridine, fused dihydropyridines and benzo[4,5]imidazo[2,1-b]quinazolines linked to ester and amide moieties via a benzene ring as new hybrid molecules. Synthetic Communications 53:23, pages 1992-2001.
Read now
Huda Kamel Mahmoud, Noha Hamed Mohamed Selim, Ahmed H. M. Elwahy, Ismail A. Abdelhamid & Hadeer M. Diab. (2023) Microwave-Assisted Hantzsch-Like Synthesis of Novel Bis(Tetrahydrobenzo[4,5]Imidazo[2,1-b]Quinazolinones). Polycyclic Aromatic Compounds 43:10, pages 8772-8784.
Read now

Articles from other publishers (2)

Amr M. Abdelmoniem, Reham E. Abdelwahab, Ahmed H. M. Elwahy & Ismail A. Abdelhamid. (2023) Regioselective synthesis of fused pyrimidines and quinazolines linked to Phenoxy‐ N ‐arylacetamide moieties as novel hybrid molecules via Biginelli‐like reaction . Journal of Heterocyclic Chemistry 60:10, pages 1699-1706.
Crossref
Magda F. Mohamed, Nada S. Ibrahim, Amna A. Saddiq, Omar A. Almaghrabi, Maha E. Al-Hazemi, Hamdi M. Hassaneen & Ismail A. Abdelhamid. (2022) Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549). Naunyn-Schmiedeberg's Archives of Pharmacology 396:4, pages 719-736.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.